InvestorsHub Logo
Followers 828
Posts 119330
Boards Moderated 16
Alias Born 09/05/2002

Re: shub post# 2678

Thursday, 10/19/2017 4:43:02 PM

Thursday, October 19, 2017 4:43:02 PM

Post# of 4859
FDA approval of Yescarta was a fait accompli, and the list price turned out to be in line with expectations. So, all told, the stock's being +2% today is a pretty good move.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News